Molecular approaches for identification of infectious agents in Wegener's granulomatosis and other vasculitides

Current Opinion in Rheumatology

Volumn 11, Issue 1, 1999, Pages 11-16

  Nikkari, Simo ^a   Relman, David A ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE EXPRESSION; HUMAN; IMAGE SUBTRACTION; INFECTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SYMPTOM; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0032927784     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199901000-00003     Document Type: Review

References (52)

1. Guillevin L, Lhote F, Ghérardi R: The spectrum and treatment of virus-associated vasculitides. Curr Opin Rheumatol 1997, 9:31-36.
2. Mandell BF, Calabrese LH. Infections and systemic vasculitis. Curr Opin Rheumatol 1998, 10:51-57.
3. Lightfoot Jr RW: Overview of the inflammatory vascular diseases. In Rheumatology, ed 1. Edited by Klippel JH, Dieppe PA. St. Louis: Mosby-Year Book; 1994: Section 6, Chapter 16, 1-6.
4. Till SH, Amos RS: Long-term follow-up of juvenile-onset cutaneous polyarteritis nodosa associated with streptococcal infection. Br J Rheumatol 1997, 36:909-911.
5. Uddhammar A, Boman J, Juto P, Rantapaa DS: Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica. Clin Exp Rheumatol 1997, 15:299-302.
6. Kelsall JT, Chalmers A, Sherlock CH, Tron VA, Kelsall AC: Microscopic polyangiitis after influenza vaccination. J Rheumatol 1997, 24:1198-1202.
7. Fredricks DN, Relman DA: Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin Microbiol Rev 1996, 9:18-33.
8. George J, Levy Y, Kallenberg CG, Shoenfeld Y: Infections and Wegener's granulomatosis - a cause and effect relationship? QJM 1997, 90:367-373. This article offers a commentary on the cause-and-effect relationship of infections and Wegener's granulomatosis.
9. de Groot K, Gross WL: Wegener's granulomatosis: disease course, assessment of activity and extent and treatment. Lupus 1998, 7:285-291. This article provides an excellent overview of the current knowledge of Wegener's granulomatosis.
10. Harman LE, Margo CE: Wegener's granulomatosis Surv Ophthalmol 1998, 42:458-480. This article provides an excellent overview of the current knowledge of Wegener's granulomatosis, with emphasis on ophthalmic aspects of the disease.
11. Hoffman GS: Treatment of Wegener's granulomatosis. time to change the standard of care? Arthritis Rheum 1997, 40:2099-2104. This is an informative editorial on the treatment of Wegener's granulomatosis.
12. Gross WL. Systemic necrotizing vasculitis. Baillieres Clin Rheumatol 1997, 11:259-284.
13. Watts RA, Scott DGI: Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 1997, 11:191-217.
14. Kallenberg CGM, Heeringa P. Pathogenesis of vasculitis. Lupus 1998, 7:280-284.
15. Dillon MJ: Childhood vasculitis. Lupus 1998, 7:259-265
16. Nowack R, Flores-Suárez LF, van der Woude FJ: New developments in pathogenesis of systemic vasculitis. Curr Opin Rheumatol 1998, 10:3-11.
17. Subra JF, Michelet C, Laporte J, Carrere F, Reboul P, Cartier F, et al: The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association? Clin Nephrol 1998, 49:15-18.
18. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA: The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996, 39:87-92.
19. Duna GF, Cotch MF, Galperin C, Hoffman DB, Hoffman GS: Wegener's granulomatosis: role of environmental exposures. Clin Exp Rheumatol 1998, 16:527-532.
20. Stegeman CA, Tervaert JWC, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM: Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994, 120:12-17.
21. Stegeman CA, Tervaert JWC, de Jong PE, Kallenberg CGM: Trimethoprimsulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996, 335:16-20.
22. Finkel TH, Torök TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DYM, et al: Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994, 343:1255-1260.
23. Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Mango T, Musiani M: Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994, 343:1260-1261.
24. Nikkari S, Mertsola J, Korvenranta H, Vainionpäa R, Toivanen P: Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994, 37:1707-1708.
25. Corman LC, Staud R: Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al. Arthritis Rheum 1995, 38:1174-1175.
26. Nikkari S, Vainionpaa R, Toivanen P, Gross WL, Mistry N, Csernok E, et al: Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al, reply. Arthritis Rheum 1995, 38:1175.
27. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S, Matsunaga Y: Human parvovirus B19 infection in Kawasaki disease. Lancet 1994, 344:58-59.
28. Leruez-Ville M, Laugé A, Monnet F, Guillevin L, Dény P: Polyarteritis nodosa and parvovirus B19. Lancet 1994, 344:263-264.
29. Moore PS: Human herpesvirus 8 variants. Lancet 1998, 351:679-680.
30. Murakami K, Ohsawa M, Hu S-X, Kanno H, Aozasa K, Nose M: Large-vessel arteritis associated with chronic active Epstein-Barr virus infection. Arthritis Rheum 1998, 41:369-373.
31. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992, 327:1490-1495.
32. Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F: Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998, 160:3594-3601.
33. Agnello V, Åbel G: Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia Arthritis Rheum 1997, 40:2007-2015.
34. Relman DA: Detection and identification of previosly unrecognized microbial pathogens. Emerg Infect Dis 1998, 4:382-389.
35. Woese C: The universal ancestor. Proc Natl Acad Sci U S A 1998, 95:6854-6859 This article presents an interesting discussion about the origins of life.
36. Relman DA, Loutit JS, Schmidt TM, Falkow S, Tompkins LS: The agent of bacillary angiomatosis: an approach to the identification of uncultured pathogens N Engl J Med 1990, 323:1573-1580.
37. Relman DA, Schmidt TM, MacDermott RP, Falkow S: Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992, 327:293-301.
38. Santamaria-Fries M, Fajardo LF, Sogin ML, Olson PD, Relman DA: Lethal infection by a previously unrecognised metazoan parasite. Lancet 1996, 347:1797-1801.
39. Rickman LS, Freeman WR, Green WR, Feldman ST, Sullivan J, Russack V, Relman DA: Uveitis caused by Tropheryma whippelii (Whipple's bacillus). N Engl J Med 1995, 332:363-366.
40. Kotilainen P, Jalava J, Meurman O, Lehtonen O-P, Rintala E, Seppalä O-P, et al: Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol 1998, 36:2205-2209. Broad-range bacterial rDNA amplification is used in a prospective, routine clinical setting.
41. Wilbrink B, van der Heijden IM, Schouls LM, van Embden JDA, Hazes JMW, Breedveld FC, Tak PP: Detection of bacterial DNA in joint samples from patients with undifferentiated arthritis and reactive arthritis, using polymerase chain reaction with universal 16S ribosomal RNA primers. Arthritis Rheum 1998, 41:535-543. 16S rDNA amplification is applied to the study of arthritis.
42. Nikkari S, Rantakokko K, Ekman P, Mottönen T, Leirisalo-Repo M, Virtala M, et al: Salmonella-triggered reactive arthritis: use of the polymerase chain reaction, immunocytochemical staining and gas chromotography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 1999, 42:84-89.
43. Jalava J, Kotilainen P, Nikkari S, Skurnik M, Vanttinen E, Lehtonen OP, et al: Use of the polymerase chain reaction and DNA sequencing for detection of Bartonella quintana in the aortic valve of a patient with culture-negative infective endocarditis. Clin Infect Dis 1995, 21:891-896.
44. Fredricks DN, Relman DA: Improved amplification of microbial DNA from blood cultures by removal of the PCR inhibitor sodium polyanetholesulfonate. J Clin Microbiol 1998, 36:2810-2816.
45. Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, et al Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993, 262:914-917.
46. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 265:1865-1869.
47. Lipkin WI, Travis GH, Carbone KM, Wilson MC: Isolation and characterization of Borna disease agent cDNA clones. Proc Natl Acad Sci U S A 1990, 87:4184-4188.
48. Marshall A, Hodgson J: DNA chips: an array of possibilities. Nat Biotechnol 1998, 16:27-31.
49. Ramsay G: DNA chips: state-of-the art. Nat Biotechnol 1998, 16:40-44.
50. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
51. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, Gilmore J, et al: Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proc Natl Acad Sci U S A 1997, 94:2150-2155. A cDNA microarray system is used to study human gene expression in rheumatoid arthritis and inflammatory bowel disease.
52. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet 1997, 350:430-436.